Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (13 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Hypurin Porcine Isophane

As of 03 Nov 2026 08:20 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2025/046 Tier 2 · issued 23 Jul 2025 (468 days ago)
Expected backno date stated by the source in the latest recorded notice
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
Scotlandno NHS Scotland alert matched to this name (separate record)

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2025/046 (23 Jul 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

PresentationStatus, as statedExpected back, as statedStated in
Vial presentations of Hypurin® Porcine Isophane, Hypurin® Porcine Neutral and Hypurin® Porcine 30/70 Mixaffected product · inferred from phrasingDiscontinued, as stated— not stated for this linenotice of 23 Jul 2025

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Hypurin Porcine Isophane

Also known as
Hypurin Porcine Isophane 100units/ml inj 1.5ml cartridges · Hypurin Porcine Isophane 100units/ml inj 10ml vials · Hypurin Porcine Isophane 100units/ml inj 3ml cartridges
BNF chemical
Isophane insulin 0601012S0 — matched on a brand name
Class
Insulin · Drugs used in diabetes · Endocrine System
SNOMED codes
3282611000001108, 3284011000001107, 4034311000001108
Suppliers named in the NHSBSA dataset
C P Pharmaceuticals Ltd (from the dataset, not from the notices)
Also recorded under
Humulin I (brand), Insulatard (brand), Insulin Isophane Human (generic) — same BNF chemical; separate pages, separate counts

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 23 Jul 2025. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Also recorded under

No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
12 Jul 2026
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-vial-presentations-of-hypurin-porcine-isophane-hypurin-porcine-neutral-and-hypurin-porcine-30-70-mix-are-being-discontinued · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.